Expresión de miRNAs en orina como herramienta de diagnóstico y pronóstico en cáncer de próstata
Rodríguez-Báez, Álvaro; Comoto-Santacruz, David Alberto; Saldaña-Rivera, Elsa; Rodríguez-Ayala, Ernesto.
Rev. sanid. mil
; 76(3): e03, jul.-sep. 2022. tab
Artículo en Español |
LILACS-Express
| ID: biblio-1432131
Documentos relacionados
M2 Macrophage-Derived Extracellular Vesicles Containing MicroRNA-501-3p Promote Colon Cancer Progression Through the SETD7/DNMT1/SOCS3 Axis.
PrLZ regulates EMT and invasion in prostate cancer via the TGF-ß1/p-smad2/miR-200 family/ZEB1 axis.
miRNA Detection for Prostate Cancer Diagnosis by miRoll-Cas: miRNA Rolling Circle Transcription for CRISPR-Cas Assay.
Unique miRomics Expression Profiles in <i>Tannerella forsythia</i>-Infected Mandibles during Periodontitis Using Machine Learning.
Characteristics of conserved microRNAome and their evolutionary adaptation to regulation of immune defense functions in the spleen of silver carp and bighead carp.
The role of miRNA in prostate cancer diagnosis, prognosis and treatment response: a narrative review.
Correlations between serum levels of microRNA-148a-3p and microRNA-485-5p and the progression and recurrence of prostate cancer.
Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis.
[MicroRNA en enfermedades autoinmunes].
Diagnostic Value of microRNA-375 as Future Biomarker for Prostate Cancer Detection: A Meta-Analysis.